See All Slides - tctmd.com

Slides

Presentation TCT 2014

Determinants of Left Ventricular Mass Regression in Patients with Severe Symptomatic Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation

Presenter: Adaya Weissler-Snir

September 16, 2014

Presentation TCT 2014

Preclosure of vascular access site with the suture-mediated ProGlide system during transfemoral TAVI and MitraClip implantation

Presenter: William KF Kong

September 16, 2014

Presentation TCT 2014

Real-World Clinical Experience of Fractional Flow Reserve Assessed With a Rapid Exchange Pressure Sensor on a MicroCatheter

Presenter: Thierry Lefevre

September 16, 2014

Presentation TCT 2014

Trancatheter Aortic Valve Implantation in Patients with Pure Severe Native Aortic Regurgitation: Results after 3 Year of Follow-Up

Presenter: Marco Luciano Rossi

September 16, 2014

Presentation TCT 2014

Heparins Crossover In Percutaneous Coronary Interventions: Is It A Real Issue With Increasing Rate Of Transradial Procedures?

Presenter: Stefano Rigattieri

September 16, 2014

Presentation TCT 2014

Real world comparison of MGuard stent versus bare metal stent for ST elevation myocardial infartion

Presenter: Agust?n Fernandez-Cisnal

September 16, 2014

Presentation TCT 2014

Cardiac Magnetic Resonance Versus Transthoracic Echocardiography for the Assessment and Quantification of Aortic Regurgitation in Patients Undergoing Transcatheter Aortic Valve___

Presenter: Henrique Ribeiro

September 16, 2014

Presentation TCT 2014

Comparison of endothelialization and inflammation between thin- and thick-strut contemporary bioerodable polymer drug-eluting stents and thick-strut fully resorbable scaffolds i___

Presenter: Kazuyuki Yahagi

September 16, 2014

Presentation TCT 2014

N-terminal Pro-B-type Natriuretic Peptide Ratio Predicts Mortality After Transcatheter Aortic Valve Replacement

Presenter: Ronald Binder

September 16, 2014

Presentation TCT 2014

Two-Year Clinical Outcome of Patients With Implantation of Second-Generation Drug-Eluting Stents in the Right Coronary Ostium in the TWENTE Trial

Presenter: Ming Kai Lam

September 16, 2014

Advertisement

Slides

Determinants of Left Ventricular Mass Regression in Patients with Severe Symptomatic Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation

Preclosure of vascular access site with the suture-mediated ProGlide system during transfemoral TAVI and MitraClip implantation

Real-World Clinical Experience of Fractional Flow Reserve Assessed With a Rapid Exchange Pressure Sensor on a MicroCatheter

Trancatheter Aortic Valve Implantation in Patients with Pure Severe Native Aortic Regurgitation: Results after 3 Year of Follow-Up

Heparins Crossover In Percutaneous Coronary Interventions: Is It A Real Issue With Increasing Rate Of Transradial Procedures?

Real world comparison of MGuard stent versus bare metal stent for ST elevation myocardial infartion

Cardiac Magnetic Resonance Versus Transthoracic Echocardiography for the Assessment and Quantification of Aortic Regurgitation in Patients Undergoing Transcatheter Aortic Valve___

Comparison of endothelialization and inflammation between thin- and thick-strut contemporary bioerodable polymer drug-eluting stents and thick-strut fully resorbable scaffolds i___

N-terminal Pro-B-type Natriuretic Peptide Ratio Predicts Mortality After Transcatheter Aortic Valve Replacement

Two-Year Clinical Outcome of Patients With Implantation of Second-Generation Drug-Eluting Stents in the Right Coronary Ostium in the TWENTE Trial

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content